Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
GZPHF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $34,176,417 | $33,231,532 | $32,406,741 | $32,427,366 |
| - Cash | $18,273,150 | $21,308,844 | $22,499,553 | $22,376,928 |
| + Debt | $12,374,236 | $11,700,946 | $11,429,843 | $9,924,321 |
| Enterprise Value | $28,277,503 | $23,623,634 | $21,337,032 | $19,974,759 |
| Revenue | $74,992,820 | $75,515,404 | $70,788,155 | $69,014,052 |
| % Growth | -0.7% | 6.7% | 2.6% | – |
| Gross Profit | $12,520,052 | $14,187,294 | $13,277,203 | $13,233,285 |
| % Margin | 16.7% | 18.8% | 18.8% | 19.2% |
| EBITDA | $4,900,974 | $6,458,025 | $6,271,308 | $5,760,174 |
| % Margin | 6.5% | 8.6% | 8.9% | 8.3% |
| Net Income | $2,835,496 | $4,055,679 | $3,966,522 | $3,719,878 |
| % Margin | 3.8% | 5.4% | 5.6% | 5.4% |
| EPS Diluted | 1.74 | 2.49 | 2.44 | 2.29 |
| % Growth | -30.1% | 2% | 6.6% | – |
| Operating Cash Flow | $3,442,427 | $4,103,625 | $6,999,076 | $5,673,497 |
| Capital Expenditures | -$1,128,144 | -$1,628,447 | -$1,383,874 | -$1,254,917 |
| Free Cash Flow | $2,314,282 | $2,475,178 | $5,615,203 | $4,418,579 |